Reducing Ovarian Cancer Mortality Through Early Detection: Approaches Using Circulating Biomarkers.

Cancer Prevention Research
Camille V TrinidadAndrew K Godwin

Abstract

More than two-thirds of all women diagnosed with epithelial ovarian cancer (EOC) will die from the disease (>14,000 deaths annually), a fact that has not changed considerably in the last three decades. Although the 5-year survival rates for most other solid tumors have improved steadily, ovarian cancer remains an exception, making it the deadliest of all gynecologic cancers and five times deadlier than breast cancer. When diagnosed early, treatment is more effective, with a 5-year survival rate of up to 90%. Unfortunately, most cases are not detected until after the cancer has spread, resulting in a dismal 5-year survival rate of less than 30%. Current screening methods for ovarian cancer typically use a combination of a pelvic examination, transvaginal ultrasonography, and serum cancer antigen 125 (CA125), but these have made minimal impact on improving mortality. Thus, there is a compelling unmet need to develop new molecular tools that can be used to diagnose early-stage EOC and/or assist in the clinical management of the disease after a diagnosis, given that more than 220,000 women are living with ovarian cancer in the United States and are at risk of recurrence. Here, we discuss the state of advancing liquid-based approach...Continue Reading

References

May 16, 1998·Proceedings of the National Academy of Sciences of the United States of America·E RacilaJ W Uhr
Jan 23, 1999·American Journal of Human Genetics·Y M LoN M Hjelm
Mar 31, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Russell Hogg, Michael Friedlander
Aug 20, 2004·The New England Journal of Medicine·Massimo CristofanilliDaniel F Hayes
Nov 1, 2005·Proceedings of the National Academy of Sciences of the United States of America·Frank DiehlBert Vogelstein
Sep 2, 2006·Clinical Colorectal Cancer·Steven J CohenNeal J Meropol
Feb 17, 2007·Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progrès Dans Les Recherches Sur Le Cancer·Robert C BastYinhua Yu
Jul 25, 2007·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·H KobayashiT Kitanaka
Sep 29, 2007·Gynecologic Oncology·Steffen RunzPeter Altevogt
Dec 7, 2007·The Lancet Oncology·Alper SevincCelalettin Camci
Jun 13, 2008·Advances in Experimental Medicine and Biology·Nicole Urban, Charles Drescher
Jul 2, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Steven J CohenNeal J Meropol
Sep 2, 2008·Nature Reviews. Drug Discovery·Martin E Hemler
Oct 10, 2008·Annual Review of Pathology·Kathleen R Cho, Ie-Ming Shih
Mar 14, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S J CohenN J Meropol
May 16, 2009·Current Opinion in Cell Biology·Mikael Simons, Graça Raposo
Nov 10, 2009·The Oncologist·Efrat DotanNeal J Meropol
Dec 1, 2007·Biomarkers in Medicine·Nathalie Scholler, Nicole Urban
Nov 9, 2010·Gynecologic Oncology·Thomas E LiggettVictor Levenson
Apr 28, 2011·CA: a Cancer Journal for Clinicians·Danijela Jelovac, Deborah K Armstrong
May 13, 2011·Nature Reviews. Cancer·Heidi SchwarzenbachKlaus Pantel
May 18, 2011·Journal of Oncology·Brandon J D ReinAshok Agarwal
Jun 7, 2011·JAMA : the Journal of the American Medical Association·Saundra S BuysUNKNOWN PLCO Project Team
Sep 29, 2011·Evidence-based Medicine·Usha Menon
Jun 1, 2012·Science Translational Medicine·Tim ForshewNitzan Rosenfeld
Sep 22, 2012·Obstetrics and Gynecology·Angela ChanAnna V Tinker
Oct 16, 2012·International Journal of Cancer. Journal International Du Cancer·Paul F PinskyChristine D Berg
Feb 20, 2013·The Journal of Cell Biology·Graça Raposo, Willem Stoorvogel
Jan 1, 2014·Proceedings of the National Academy of Sciences of the United States of America·Safinur AtayAndrew K Godwin
Jan 8, 2014·Journal of Translational Medicine·Miharu KobayashiGregory E Rice
Jan 23, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Luis A Diaz, Alberto Bardelli
Apr 23, 2014·Nature Biotechnology·Hyungsoon ImHakho Lee
Sep 13, 2014·Lab on a Chip·J McGrathH Bridle

❮ Previous
Next ❯

Citations

Jun 11, 2020·JAMA Surgery·David L Bartlett
Mar 7, 2020·Cancer Prevention Research·Margie L Clapper, Carolyn Y Fang
Jan 26, 2021·Translational Oncology·Robin AugustineAnwarul Hasan
Feb 19, 2021·Frontiers in Oncology·Xiaxia ManSongling Zhang
May 18, 2021·Frontiers in Cell and Developmental Biology·Toshihiko TakeiwaSatoshi Inoue

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.